How to Buy Emergent Biosolutions Stock
Emergent Biosolutions Inc
Emergent Biosolutions is a pharmaceutical company located in Maryland, United States, which is part of the Healthcare sector, and is traded under the ticker EBS on the NYSE exchange.
Emergent Biosolutions stock last closed at $6.25, down 5.3% from the previous day, and has increased 3.48% in one year. It has overperformed other stocks in the Drug Manufacturers - Specialty & Generic industry by 0.39 percentage points. Emergent Biosolutions stock is currently +55.47% from its 52-week low of $4.02, and -58.61% from its 52-week high of $15.10.
There are currently 54.28M EBS shares outstanding. The market value of EBS is $339.24M. In the past 24 hours, 743,000 EBS shares were traded.
How to Buy Emergent Biosolutions Stock
Not sure how to invest in Emergent Biosolutions stock? Here's how.
- Figure out where to buy Emergent Biosolutions stock: You need to choose a stock brokerage, but don't worry - we've sifted through dozens of online brokerages and apps to help you choose where to buy Emergent Biosolutions stock.
- Sign up for a brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've selected.
- Deposit funds into your brokerage account: Choose your method of payment and add your info.
- Evaluate Emergent Biosolutions stock: The Emergent Biosolutions ticker symbol is EBS. Is Emergent Biosolutions stock a good investment? Should you buy shares of EBS? How do EBS's underlying business fundamentals look? Do top analysts think Emergent Biosolutions is a good buy? Why has EBS's stock price moved recently? (Hint: Our stock research website can help you evaluate if EBS is a good stock to buy).
- Place your EBS purchase: Decide if you will purchase EBS shares at the current market price or use a limit order to buy EBS stock at a particular price.
- Watch your investment in EBS: Create a watchlist to watch your investment in Emergent Biosolutions stock.
Step 1: Figure out where to buy Emergent Biosolutions stock
You will need an online brokerage account to access the NYSE market and buy EBS shares.
Our preferred brokerage: eToro
In our opinion, eToro is the best place to buy stocks. Here's why:
- Invest in stocks with zero commissions: Invest without commissions.
- Buy fractional shares: Even if you don't have the money to buy a full share, you can still purchase the stock.
- Access to global markets: From Tech to Real Estate, New York to Shanghai (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's top stock exchanges.
- Social investing: eToro boasts a community with more than 20 million users globally. Talk to, learn from, and copy the crypto trades of top investors.
- Security: eToro is a regulated and licensed fintech leader.
- Buy other financial assets: Such as ETFs and cryptocurrencies.
Get $10 towards your purchase of shares by signing up for an account with eToro today. This offer is only for US users.
Open eToro AccountStep 2: Sign up for a brokerage account
Now that you've picked the right brokerage, you need to fill out some personal information so you can invest in EBS stock today.
How to Open a New Investment Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Provide your personal data to create your new trading account.
- Send your application by clicking the "Create Account" button. Get started with eToro today
Step 3: Deposit funds into your brokerage account
Now that you've created your account on the best app for stock investing, you need to deposit funds:
Check out the video below to see the process of transferring funds into your brokerage account.
Step 4: Evaluate Emergent Biosolutions stock
Once you have selected the best place to buy Emergent Biosolutions stock, it's absolutely critical to evaluate their stock before you invest, so you truly comprehend the risk and upside.
Emergent Biosolutions shares data
Emergent Biosolutions Overview
WallStreetZen was created to help part-time investors perform more accurate fundamental analysis in minutes instead of hours.
You can view all of the due diligence checks on EBS's stock page.
Is EBS stock undervalued?
Investors use many financial metrics, analyses, models, and charts to gauge EBS's true value.
Using relative valuations measures:
- EBS may be undervalued based on its P/B ratio of 0.61x, relative to Drug Manufacturers - Specialty & Generic industry P/B ratio of 2.26x
You can do additional valuation analysis on EBS's stock here.
EBS Financial Health Overview
Passed Health Checks:
- EBS profit margin has gone up from -47.7% to -13.6% in the past year.
- There are more short-term assets than short-term liabilities on the EBS balance sheet.
Failed Health Checks:
- Total EBS debt is higher than 5 years ago, relative to shareholder equity.
- EBS's operating cash flow of $110.10M allows it to safely service it's debt of $665.70M.
- EBS earnings of -$900.00k is not sufficient to cover its interest payments.
- There are more long-term liabilities than short-term assets on the EBS balance sheet.
- EBS has a relatively high debt to equity ratio of 1.58.
Is EBS stock a Buy, Hold, or Sell, according to Wall Street analysts?
Out of 1 Wall Street analysts who give forecasts on EBS, the consensus analyst rating on Emergent Biosolutions is a Buy
It's important to note that analyst forecasts are not recommendations, nor are they investment advice.
You can dive deeper into what analysts are saying on the Emergent Biosolutions stock forecast page.
EBS Technical Indicators
How is EBS performing as a company?
Last year, EBS revenue was $965.40M. Over the last five year, EBS's revenue has grown by -2.71% per year. This was slower than the Drug Manufacturers - Specialty & Generic industry average of 9.6%.
Dive into EBS's earnings and revenue performance here.
Who is buying/selling EBS?
Over the past year, executives and large shareholders at EBS have sold more shares than they have bought.
Coleen Glessner, EVP Quality Ethics and CPL of EBS, was the latest EBS insider to sell. They sold $8,280.87 worth of EBS shares on Jun 8, 2025.
Get more info about who owns EBS shares here.
Can I rely on EBS as an income stream?
No, Emergent Biosolutions doesn't provide an income stream by paying out dividends.
What others are saying about EBS
One of the primary reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to find out what other traders have to say.
Step 5: Place your EBS purchase
There are two main order types:
- Market order: A market order is an order to buy or sell a stock at the best available price.
Market orders are usually the best for newer investors. - Limit order: A limit order enables you to buy or sell a security at a specific price (or better).
If you want to ensure you're buying or selling at a particular dollar amount limit, place a limit order.
Click the Open Trade button and your broker will execute your order.
If you need additional info about buying stocks on eToro, watch the helpful video below:
Step 6: Watch your investment in EBS
Now that you own some EBS shares, you'll want to stay up-to-date on your shares.
Create a watchlist to see the latest developments about your EBS stock.
EBS Feed
How to Buy Stock in Emergent Biosolutions
To reiterate, here are the 6 steps you need to take to buy Emergent Biosolutions stock right now:
- Figure out where to buy Emergent Biosolutions stock
- Sign up for a brokerage account
- Deposit funds into your brokerage account
- Evaluate Emergent Biosolutions stock
- Place your EBS purchase
- Watch your investment in EBS
If you are looking for a online brokerage, eToro is our recommended venue.
Get Started with eToro TodayIf you want to get notifications regarding your new investment in Emergent Biosolutions, click the button below.
Related "How To" Guides
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.